Literature DB >> 18396098

Natural evolution of carpal tunnel syndrome in untreated patients.

Fernando Ortiz-Corredor1, Fernando Enríquez, Jorge Díaz-Ruíz, Nixon Calambas.   

Abstract

OBJECTIVE: To describe the clinical and electrophysiological evolution of a group of patients diagnosed with carpal tunnel syndrome (CTS) who have not undergone any type of treatment (injections, braces or surgery).
METHODS: Clinical and electrophysiological monitoring was done consecutively in a series of patients who were admitted with a diagnosis of CTS. The average time for follow-up was 2 years. The Historic and objective Classification scale (HiOb) was used to establish the severity of the disease in the test group, and neuro conductions were done to determine the electrophysiological classification.
RESULTS: A total of 132 patients were monitored. In 31 patients (23.4% of the cases), the HiOb classification deteriorated, 28.8% remained stable, and 47.6% showed recovery. In the nerve conduction studies, 10 cases (7.6%) exhibited electrophysiological deterioration, 67.4% remained constant and 25% improved.
CONCLUSIONS: A significant percentage of patients with carpal tunnel syndrome had no change in their clinical and electrophysiological condition, while some improved spontaneously without treatment. SIGNIFICANCE: Given that most patients diagnosed with CTS remain stable or even improve over time, a conservative treatment may be all that is needed in a selection of patients with this disorder.

Entities:  

Mesh:

Year:  2008        PMID: 18396098     DOI: 10.1016/j.clinph.2008.02.012

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  8 in total

1.  Progression of carpal tunnel syndrome according to electrodiagnostic testing in nonoperatively treated patients.

Authors:  Mark van Suchtelen; Stéphanie J E Becker; Jillian S Gruber; David Ring
Journal:  Arch Bone Jt Surg       Date:  2014-09-15

2.  Role of Biomechanical Factors in Resolution of Carpal Tunnel Syndrome Among a Population of Workers.

Authors:  Amilcar Cardona; Matthew S Thiese; Jay Kapellusch; Andrew Merryweather; Eric Wood; Kurt T Hegmann
Journal:  J Occup Environ Med       Date:  2019-04       Impact factor: 2.162

3.  Current options for nonsurgical management of carpal tunnel syndrome.

Authors:  Hans Carlson; Agatha Colbert; Jennifer Frydl; Elizabeth Arnall; Molly Elliot; Nels Carlson
Journal:  Int J Clin Rheumtol       Date:  2010-02

4.  Outcomes and cost-effectiveness of carpal tunnel injections using sonographic needle guidance.

Authors:  Tony Makhlouf; N Suzanne Emil; Wilmer L Sibbitt; Roderick A Fields; Arthur D Bankhurst
Journal:  Clin Rheumatol       Date:  2013-11-26       Impact factor: 2.980

5.  Injection versus Decompression for Carpal Tunnel Syndrome-Pilot trial (INDICATE-P)-protocol for a randomised feasibility study.

Authors:  Will Mason; Daniel Ryan; Asif Khan; Hui-Ling Kerr; David Beard; Jonathan Cook; Ines Rombach; Cushla Cooper
Journal:  Pilot Feasibility Stud       Date:  2017-04-24

Review 6.  Update on Efficacy of Conservative Treatments for Carpal Tunnel Syndrome.

Authors:  Teemu Karjalanen; Saara Raatikainen; Kati Jaatinen; Vieda Lusa
Journal:  J Clin Med       Date:  2022-02-11       Impact factor: 4.241

7.  Diacutaneous Fibrolysis Intervention in Patients with Mild to Moderate Carpal Tunnel Syndrome May Avoid Severe Cases in Elderly: A Randomized Controlled Trial.

Authors:  Sandra Jiménez-Del-Barrio; Luis Ceballos-Laita; Elena Bueno-Gracia; Sonia Rodríguez-Marco; Santos Caudevilla-Polo; Elena Estébanez-de-Miguel
Journal:  Int J Environ Res Public Health       Date:  2022-09-02       Impact factor: 4.614

8.  Determinants of Remission in Medically Treated Carpal Tunnel Syndrome: Study from Central India.

Authors:  Ajoy Sodani; Raunak Dani; Mukesh Dube; Dinesh Choukesey; Sunil Athale
Journal:  Ann Indian Acad Neurol       Date:  2018 Jan-Mar       Impact factor: 1.383

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.